JP2024510207A5 - - Google Patents
Info
- Publication number
- JP2024510207A5 JP2024510207A5 JP2023555534A JP2023555534A JP2024510207A5 JP 2024510207 A5 JP2024510207 A5 JP 2024510207A5 JP 2023555534 A JP2023555534 A JP 2023555534A JP 2023555534 A JP2023555534 A JP 2023555534A JP 2024510207 A5 JP2024510207 A5 JP 2024510207A5
- Authority
- JP
- Japan
- Prior art keywords
- methoxy
- diazabicyclo
- fluoro
- fluoroquinazoline
- nonane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163160436P | 2021-03-12 | 2021-03-12 | |
| US63/160,436 | 2021-03-12 | ||
| US202163288965P | 2021-12-13 | 2021-12-13 | |
| US63/288,965 | 2021-12-13 | ||
| PCT/US2022/020230 WO2022192790A1 (en) | 2021-03-12 | 2022-03-14 | Kras inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024510207A JP2024510207A (ja) | 2024-03-06 |
| JP2024510207A5 true JP2024510207A5 (https=) | 2025-03-25 |
Family
ID=81074021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555534A Pending JP2024510207A (ja) | 2021-03-12 | 2022-03-14 | Ｋｒａｓ阻害剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240217982A1 (https=) |
| EP (1) | EP4305037B1 (https=) |
| JP (1) | JP2024510207A (https=) |
| KR (1) | KR20230169968A (https=) |
| AU (1) | AU2022232460A1 (https=) |
| BR (1) | BR112023017661A2 (https=) |
| CA (1) | CA3210383A1 (https=) |
| ES (1) | ES3014892T3 (https=) |
| IL (1) | IL305572A (https=) |
| MX (1) | MX2023010429A (https=) |
| WO (1) | WO2022192790A1 (https=) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019195609A2 (en) | 2018-04-04 | 2019-10-10 | Arvinas Operations, Inc. | Modulators of proteolysis and associated methods of use |
| US20250059205A1 (en) * | 2021-04-29 | 2025-02-20 | Amgen Inc. | Heterocyclic Compounds and Methods of Use |
| WO2023114733A1 (en) * | 2021-12-13 | 2023-06-22 | Quanta Therapeutics, Inc. | Kras modulators and uses thereof |
| CA3243798A1 (en) | 2022-02-09 | 2023-08-17 | Quanta Therapeutics, Inc. | Kras Modulators and Their Uses |
| JP2025510572A (ja) | 2022-03-08 | 2025-04-15 | レボリューション メディシンズ インコーポレイテッド | 免疫不応性肺癌を治療するための方法 |
| CN118344386A (zh) * | 2023-01-13 | 2024-07-16 | 苏州泽璟生物制药股份有限公司 | 取代桥环类抑制剂及其制备方法和应用 |
| WO2023179629A1 (zh) * | 2022-03-22 | 2023-09-28 | 苏州泽璟生物制药股份有限公司 | 取代桥环类抑制剂及其制备方法和应用 |
| MX2024011631A (es) * | 2022-03-25 | 2024-09-30 | Lilly Co Eli | Inhibidores de kras. |
| WO2023230190A1 (en) | 2022-05-25 | 2023-11-30 | Quanta Therapeutics, Inc. | Pyrimidine based modulators and uses thereof |
| WO2023240263A1 (en) | 2022-06-10 | 2023-12-14 | Revolution Medicines, Inc. | Macrocyclic ras inhibitors |
| TW202416976A (zh) * | 2022-09-16 | 2024-05-01 | 大陸商南京明德新藥研發有限公司 | 含六氫螺環［環丙烷—１，２＇—吡咯𠯤］的化合物 |
| WO2024061365A1 (zh) * | 2022-09-22 | 2024-03-28 | 成都奥睿药业有限公司 | 嘧啶并环类化合物及其制备方法与用途 |
| EP4631942A1 (en) | 2022-10-21 | 2025-10-15 | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | Pan-kras degrading agent, and preparation method therefor and use thereof |
| JP2025536369A (ja) | 2022-10-21 | 2025-11-05 | リーディングタック ファーマシューティカル（シャオシン）カンパニー，リミテッド | Ｋｒａｓ ｇ１２ｄ分解剤及びその製造方法並びに応用 |
| US12448399B2 (en) | 2023-01-26 | 2025-10-21 | Arvinas Operations, Inc. | Cereblon-based KRAS degrading PROTACs and uses related thereto |
| KR20260041941A (ko) | 2023-03-15 | 2026-03-27 | 콴타 테라퓨틱스, 인크. | Kras 조절 인자 및 이의 용도 |
| AU2024241633A1 (en) | 2023-03-30 | 2025-11-06 | Revolution Medicines, Inc. | Compositions for inducing ras gtp hydrolysis and uses thereof |
| CR20250420A (es) | 2023-04-07 | 2025-11-20 | Revolution Medicines Inc | Inhibidores macrocíclicos de ras |
| AR132338A1 (es) | 2023-04-07 | 2025-06-18 | Revolution Medicines Inc | Inhibidores de ras |
| CN121100123A (zh) | 2023-04-14 | 2025-12-09 | 锐新医药公司 | Ras抑制剂的结晶形式 |
| CN121464140A (zh) | 2023-04-14 | 2026-02-03 | 锐新医药公司 | Ras抑制剂的结晶形式、含有其的组合物及其使用方法 |
| TW202508595A (zh) | 2023-05-04 | 2025-03-01 | 美商銳新醫藥公司 | 用於ｒａｓ相關疾病或病症之組合療法 |
| US20250049810A1 (en) | 2023-08-07 | 2025-02-13 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| US20250109147A1 (en) | 2023-09-08 | 2025-04-03 | Gilead Sciences, Inc. | Kras g12d modulating compounds |
| AU2024360465A1 (en) | 2023-10-12 | 2026-04-09 | Revolution Medicines, Inc. | Macrocyclic ras inhibitors |
| WO2025171296A1 (en) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Ras inhibitors |
| TW202547461A (zh) | 2024-05-17 | 2025-12-16 | 美商銳新醫藥公司 | Ｒａｓ抑制劑 |
| WO2025255438A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026006747A1 (en) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026015801A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015796A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015790A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015825A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Use of ras inhibitor for treating pancreatic cancer |
| WO2026050446A1 (en) | 2024-08-29 | 2026-03-05 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026072904A2 (en) | 2024-09-26 | 2026-04-02 | Revolution Medicines, Inc. | Compositions and methods for treating lung cancer |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4475196A (en) | 1981-03-06 | 1984-10-02 | Zor Clair G | Instrument for locating faults in aircraft passenger reading light and attendant call control system |
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| WO2017172979A1 (en) * | 2016-03-30 | 2017-10-05 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use |
| US10745385B2 (en) * | 2017-05-25 | 2020-08-18 | Araxes Pharma Llc | Covalent inhibitors of KRAS |
| WO2021031952A1 (zh) * | 2019-08-16 | 2021-02-25 | 劲方医药科技(上海)有限公司 | 氧代六元环并嘧啶类化合物，其制法与医药上的用途 |
| WO2022061251A1 (en) * | 2020-09-18 | 2022-03-24 | Plexxikon Inc. | Compounds and methods for kras modulation and indications therefor |
| EP4291199A4 (en) * | 2021-02-09 | 2025-06-18 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
-
2022
- 2022-03-14 JP JP2023555534A patent/JP2024510207A/ja active Pending
- 2022-03-14 WO PCT/US2022/020230 patent/WO2022192790A1/en not_active Ceased
- 2022-03-14 CA CA3210383A patent/CA3210383A1/en active Pending
- 2022-03-14 IL IL305572A patent/IL305572A/en unknown
- 2022-03-14 AU AU2022232460A patent/AU2022232460A1/en active Pending
- 2022-03-14 BR BR112023017661A patent/BR112023017661A2/pt unknown
- 2022-03-14 MX MX2023010429A patent/MX2023010429A/es unknown
- 2022-03-14 EP EP22714316.1A patent/EP4305037B1/en active Active
- 2022-03-14 KR KR1020237034230A patent/KR20230169968A/ko active Pending
- 2022-03-14 ES ES22714316T patent/ES3014892T3/es active Active
- 2022-03-14 US US18/550,237 patent/US20240217982A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024510207A5 (https=) | ||
| JP2024510606A5 (https=) | ||
| JP2024532735A5 (https=) | ||
| RU2019120986A (ru) | Фармацевтическая комбинация, содержащая ингибитор alk и ингибитор shp2 | |
| ES2805087T3 (es) | Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la cinasa RET | |
| JP2025535046A (ja) | Ｋｒａｓ ｇ１２ｃ変異タンパク質の複素環阻害剤及びその使用 | |
| CN107406454B (zh) | 优化的联合用药及其治疗癌症和自身免疫疾病的用途 | |
| EA201891463A1 (ru) | ПРОИЗВОДНЫЕ ПИРАЗОЛО[1,5-a]ПИРАЗИН-4-ИЛА В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-КИНАЗЫ (JAK) | |
| CN108366992A (zh) | 蛋白水解靶向嵌合体化合物及其制备和应用方法 | |
| BR112020019385A2 (pt) | Inibidores de shp2 fosfatase e métodos de uso dos mesmos | |
| JP2021523159A5 (https=) | ||
| JP2013539777A5 (https=) | ||
| JP2015157843A5 (https=) | ||
| RU2018134981A (ru) | Конъюгаты, содержащие ингибиторы RIPK2 | |
| RU2018123825A (ru) | Соединения и способы для модуляции киназ, и показания для этого | |
| TW201701879A (zh) | Ｉｒａｋ４抑制劑組合 | |
| RU2014119250A (ru) | Производные 8-карбамоил-2-(2,3-дизамещенного пирид-6-ил)-1,2,3,4-тетрагидроизохинолина в качестве индуцирующих апоптоз средств для лечения рака и иммунных и аутоиммунных заболеваний | |
| CN113387931A (zh) | 一种具有抑制或降解蛋白激酶的化合物及其制备方法和药学上的应用 | |
| WO2008042422A3 (en) | Bicyclic and tricyclic derivatives as thrombin receptor antagonists | |
| ME02203B (me) | Hinolin i hinoksalin derivati kao inhibitori kinaza | |
| JP2013510125A5 (https=) | ||
| JP2013518892A5 (https=) | ||
| JP2010132689A (ja) | ジヒドロピラゾロピリミジノン誘導体 | |
| CA3071760A1 (en) | Combination of atr kinase inhibitors and pd-1/pd-l1 inhibitors | |
| HRP20201469T1 (hr) | Derivati tetrahidroizokinolina |